Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12188/29923
DC FieldValueLanguage
dc.contributor.authorAngelovska Petrushevska, Natalijaen_US
dc.contributor.authorMitreski, Nenaden_US
dc.contributor.authorAngelovska, Biljanaen_US
dc.contributor.authorKlisarovska, Violetaen_US
dc.contributor.authorAngelovski, Tomeen_US
dc.date.accessioned2024-04-08T06:25:35Z-
dc.date.available2024-04-08T06:25:35Z-
dc.date.issued2014-
dc.identifier.urihttp://hdl.handle.net/20.500.12188/29923-
dc.language.isoenen_US
dc.publisherOxford University Press on behalf of the European Society for Medical Oncologyen_US
dc.relation.ispartofAnnals of Oncology 2014en_US
dc.titleTrastuzumab in Her-2 positive advancd gastric carcinoma – long term survivorsen_US
dc.typeProceeding articleen_US
dc.relation.conferenceESMO 14th World Congress on Gastrointestinal Cancer, Barcelona, Spain, 25-28 June 2014.en_US
item.grantfulltextopen-
item.fulltextWith Fulltext-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
Appears in Collections:Faculty of Medicine: Conference papers
Files in This Item:
File Description SizeFormat 
2014 ESMO.pdf69.16 kBAdobe PDFView/Open
Show simple item record

Page view(s)

27
checked on May 20, 2024

Download(s)

3
checked on May 20, 2024

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.